At IHC-Online we offer all types of Cancer markers as screening, monitoring and follow-up tests for various types of cancer. These tests are considered late-stage markers of cancer and are as follows:
Alpha-Fetoprotein, Human Cord Serum (hAFP):
A major fetal serum glycoprotein, classified as an oncofetal protein, synthesized in the liver and yolk sac and developing fetal gastrointestinal tract.
A useful marker for hepatoma and yolk sac tumors. Higher levels are also reported in gastric cancers.
Cancer-associated Antigen, Ovarian Tumor (CA125):
A glycoprotein normally present in serum at around 30 units/ml; significantly elevated in serum samples of women with metastatic breast and ovarian cancer.
Prognostic as well as monitoring indicator for patients with advanced breast and ovarian cancer.
Cancer-associated antigen, Breast Tumor (CA 15-3):
A glycoprotein usually present in serum at about 30 units/ml; significantly elevated in serum of women with metastatic breast cancer.
Prognostic as well as monitoring indicator for patients with breast cancer.
Cancer-associated Antigen, Gastrointestinal (CA 19-9):
A glycoprotein that is mainly secreted by the pancreatic and biliary duct cells.
Significantly elevated (greater than 37 units/ml) are considered risk for colo-rectal, gastric, and pancreatic cancer.
Carcinoembryonic Antigen (CEA)
A cell surface glycoprotein that is elevated in 35-40% of patients with adenocarcinoma of the colon, 30% of patients with cancer of the lung, liver, pancreas, breast, colon, head, neck, cervix and prostate.
Elevated levels are related to the stage and extent of the disease, the degree of differentiation of the tumor, and the site of metastasis.
Cancer-association Antigen, TAG-72 (CA72-4):
A glycoprotein that is elevated with breast, pancreatic, ovarian, colon, and stomach cancer.
Neuron-specific Enolase (NSE):
A useful tumor marker for monitoring treatment of patients with small cell lung cancer.
Detects recurrent disease and metastatic spread long before other diagnostic methods.
S-100 Protein:
A valuable tool for detecting post extracorporeal circulation brain damage.
Effective marker for malignant melanoma metastasis.
Tissue Polypeptide, Human Breast Epithelium Carcinoma Cell Line (hTPA):
High levels of this marker can be associated with gastrointestinal, lung, pancreas and bladder cancer.
Shows a significant correlation with the stage of the disease, tumor size and metastasis.
Multiple Myeloma and MGUS:
Marker for multiple myeloma.
The primary use of tumor markers in medicine today is in monitoring the efficacy of cancer treatments. However, markers can also be used in the screening, and diagnosis of cancer as well as long term follow-up after treatment has been completed.
For more information call 403-288-4880 or
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Conditions 